Malyala P - Search Results

1

Rational design of small molecules as vaccine adjuvants.

Wu TY, Singh M, Miller AT, De Gregorio E, Doro F, D'Oro U, Skibinski DA, Mbow ML, Bufali S, Herman AE, Cortez A, Li Y, Nayak BP, Tritto E, Filippi CM, Otten GR, Brito LA, Monaci E, Li C, Aprea S, Valentini S, Calabrό S, Laera D, Brunelli B, Caproni E, Malyala P, Panchal RG, Warren TK, Bavari S, O'Hagan DT, Cooke MP, Valiante NM. Wu TY, et al. Among authors: malyala p. Sci Transl Med. 2014 Nov 19;6(263):263ra160. doi: 10.1126/scitranslmed.3009980. Sci Transl Med. 2014. PMID: 25411473

2

Micro/nanoparticle adjuvants: preparation and formulation with antigens.

Malyala P, Singh M. Malyala P, et al. Methods Mol Biol. 2010;626:91-101. doi: 10.1007/978-1-60761-585-9_7. Methods Mol Biol. 2010. PMID: 20099123

3

Vaccine adjuvant formulations: a pharmaceutical perspective.

Brito LA, Malyala P, O'Hagan DT. Brito LA, et al. Among authors: malyala p. Semin Immunol. 2013 Apr;25(2):130-45. doi: 10.1016/j.smim.2013.05.007. Epub 2013 Jul 12. Semin Immunol. 2013. PMID: 23850011 Review.

4

Physicochemical and functional characterization of vaccine antigens and adjuvants.

Dey AK, Malyala P, Singh M. Dey AK, et al. Among authors: malyala p. Expert Rev Vaccines. 2014 May;13(5):671-85. doi: 10.1586/14760584.2014.907528. Epub 2014 Apr 4. Expert Rev Vaccines. 2014. PMID: 24702271 Free article. Review.

5

The Preparation and Physicochemical Characterization of Aluminum Hydroxide/TLR7a, a Novel Vaccine Adjuvant Comprising a Small Molecule Adsorbed to Aluminum Hydroxide.

Malyala P, Laera D, Cianetti S, Bufali S, Aggravi M, Ianni E, Judge C, Otten G, Singh M, O'Hagan DT. Malyala P, et al. J Pharm Sci. 2018 Jun;107(6):1577-1585. doi: 10.1016/j.xphs.2018.01.024. Epub 2018 Feb 6. J Pharm Sci. 2018. PMID: 29421216

6

Enhancing the therapeutic efficacy of CpG oligonucleotides using biodegradable microparticles.

Malyala P, O'Hagan DT, Singh M. Malyala P, et al. Adv Drug Deliv Rev. 2009 Mar 28;61(3):218-25. doi: 10.1016/j.addr.2008.12.009. Epub 2009 Jan 11. Adv Drug Deliv Rev. 2009. PMID: 19168103 Review.

7

Gaps in knowledge and prospects for research of adjuvanted vaccines.

Seder R, Reed SG, O'Hagan D, Malyala P, D'Oro U, Laera D, Abrignani S, Cerundolo V, Steinman L, Bertholet S. Seder R, et al. Among authors: malyala p. Vaccine. 2015 Jun 8;33 Suppl 2:B40-3. doi: 10.1016/j.vaccine.2015.03.057. Vaccine. 2015. PMID: 26022566

8

Novel adjuvant Alum-TLR7 significantly potentiates immune response to glycoconjugate vaccines.

Buonsanti C, Balocchi C, Harfouche C, Corrente F, Galli Stampino L, Mancini F, Tontini M, Malyala P, Bufali S, Baudner B, De Gregorio E, Valiante NM, O'Hagan DT, Rappuoli R, D'Oro U. Buonsanti C, et al. Among authors: malyala p. Sci Rep. 2016 Jul 21;6:29063. doi: 10.1038/srep29063. Sci Rep. 2016. PMID: 27439378 Free PMC article.

9

Polylactide-co-glycolide microparticles with surface adsorbed antigens as vaccine delivery systems.

Singh M, Kazzaz J, Ugozzoli M, Malyala P, Chesko J, O'Hagan DT. Singh M, et al. Among authors: malyala p. Curr Drug Deliv. 2006 Jan;3(1):115-20. doi: 10.2174/156720106775197565. Curr Drug Deliv. 2006. PMID: 16472100 Review.

10

Endotoxin limits in formulations for preclinical research.

Malyala P, Singh M. Malyala P, et al. J Pharm Sci. 2008 Jun;97(6):2041-4. doi: 10.1002/jps.21152. J Pharm Sci. 2008. PMID: 17847072 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Search Page

Filters